Certified by Founder Lodge
Zetagen Therapeutics
United States - Syracuse, New York
START UP
1 Disclosed Funding Rounds $9,790,000
0 Participating Investments
-
Founded date
2015
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Founded in 2015, Zetagen is a private, clinical-stage, biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of metastatic bone cancers and osteologic interv
Date | Round | Raised | Participating Investors |
---|---|---|---|
August, 14 ,2023 | Series B | $9,790,000 |